“Combination therapy of omalizumab with house dust mite immunotherapy in chronic spontaneous urticaria associated with sensitization to dust mites-case series” (2021) Indian Journal of Case Reports, 7(11), pp. 469–472. doi:10.32677/ijcr.v7i11.3107.